The initial description in 1980 by Furchgott and
|
|
- Roland Cecil Austin
- 5 years ago
- Views:
Transcription
1 MINI-REVIEW: EXPERT OPINIONS Testing Endothelial Vasomotor Function Nitric Oxide, a Multipotent Molecule Peter Ganz, MD; Joseph A. Vita, MD The initial description in 1980 by Furchgott and Zawadzki 1 of endothelium-derived vasodilator factor has stimulated more than 2 decades of intense research to delineate the basic biology of the endothelium and its importance in the clinical setting. 2 Endotheliumderived vasodilator factor has been identified as nitric oxide (NO). 2 It is formed in endothelial cells from the amino acid L-arginine by endothelial isoform of NO synthase (enos), which is the product of the NOS3 gene. 2,3 In addition to producing NO constitutively, the enzyme may be stimulated to increase NO synthesis by a variety of physiological agonists, shear stress, and pharmacological agents. Although discovered as a vasodilator, NO mediates many of the protective functions of the endothelium. 4 It limits vascular recruitment of leukocytes by inhibiting the expression of proinflammatory cytokines, chemokines, and leukocyte adhesion molecules. 2,4 It inhibits vascular smooth muscle proliferation and platelet adhesion and aggregation. 2,4 NO also inhibits the production of tissue factor, a molecule that plays a critical role in the propensity of disrupted atherosclerotic plaques to cause intravascular thrombosis. 5 In the setting of risk factors and experimental atherosclerosis, loss of the biological activity of endothelium-derived NO is accompanied by other alterations in endothelial phenotype that further increase the propensity for vasoconstriction, thrombosis, inflammation, and cellular proliferation in the vascular wall. 6 Thus, endothelial dysfunction has the potential to contribute to key events in the course of human atherosclerosis. NO in Health and Atherosclerosis: Relationship With Risk Factors and Hemodynamic Stress The experimental observations of Furchgott and others have stimulated translational research to elucidate the importance of endothelium-dependent vasodilation in human coronary atherosclerosis. Accordingly, Ludmer and colleagues 7 administered the endothelium-dependent dilator acetylcholine into the coronary arteries of subjects undergoing cardiac catheterization. Acetylcholine induced dilation of normal epicardial coronary arteries but induced abnormal vasoconstriction, indicative of endothelial dysfunction, in patients with angiographic evidence of atherosclerosis. The concept of endothelial vasodilator dysfunction in atherosclerotic human coronary arteries was reinforced by similar findings when other stimuli to NO release were tested, including flow-mediated dilation, sympathetic activation, serotonin, and adenosine diphosphate. 4 The loss of endothelium-dependent dilation occurs in the earliest stages of atherosclerosis. In fact, it has been linked to each of the known atherogenic risk factors, including several forms of dyslipidemia, hypertension, diabetes mellitus, cigarette smoking, aging, menopause, family history of premature atherosclerosis, and hyperhomocysteinemia The endothelium is a direct, sensitive target for the damaging effects of atherogenic risk factors, as evidenced from the experimental introduction of risk factors into healthy subjects. For example, elevation of blood homocysteine by administration of its precursor methionine, 11 generation of lipoprotein remnant The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. From the Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass (P.G.), and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass (J.A.V.). Correspondence to Peter Ganz, MD, Brigham and Women s Hospital, 75 Francis St, Boston, MA pganz@aol.com (Circulation. 2003;108: ) 2003 American Heart Association, Inc. Circulation is available at DOI: /01.CIR F9 2049
2 2050 Circulation October 28, 2003 particles by feeding a high-fat meal, 12 or infusion of glucose to raise its plasma level to mimic hyperglycemia of diabetes mellitus 13 leads to endothelial vasodilator dysfunction in a span of just a few hours. Endothelial dysfunction is also perturbed by abnormal hemodynamic stresses. Bifurcations in human coronary arteries, sites of predilection toward atherosclerosis, show impaired endothelium-dependent vasodilation before atherosclerosis is detected. 14 Although atherosclerotic stenoses in large arteries can restrict blood flow, second-to-second regulation of flow in response to metabolic and other stimuli is generally accomplished in resistance arterioles. Although atherosclerosis is typically absent from these small vessels, atherogenic risk factors also impair endothelium-dependent vasodilation at these sites and thereby contribute to myocardial ischemia In addition, endothelial dysfunction has been detected in several peripheral vascular beds. 18,19 This has led to the concept of generalized, systemic nature of endothelial dysfunction 20 and has facilitated endothelial function testing in readily accessible vascular beds. Assessment of Endothelium-Dependent Vasodilator Function in Humans As originally described by Ludmer and colleagues, 7 endothelial function in human coronary arteries can be assessed by measuring the vasomotor responses of epicardial arteries by quantitative coronary angiography in response to graded concentrations of acetylcholine or other agonists. Endothelial function in coronary resistance vessel responses can be assessed at the same time by Doppler flow measurements. 9,21 This method has been considered the gold standard against which other tests of endothelial function have been compared. It has been particularly useful for developing a framework that relates disturbed coronary pathophysiology to myocardial ischemia in patients with coronary artery disease. 22 This invasive method is of necessity restricted to patients undergoing clinically indicated cardiac catheterization. Endothelial function of forearm resistance vessels can be assessed by measurement of forearm blood flow using straingauge plethysmography in conjunction with intra-arterial infusion of endothelium-dependent agonists and selective pharmacological probes. 23 This approach has been used primarily in studies intended to elucidate the basic mechanisms that underlie endothelial dysfunction in humans. The general applicability of this technique to broader populations is limited by the requirement for an intra-arterial catheter. Assessment of endothelium-dependent, flow-mediated dilation of the brachial artery using high-resolution ultrasound has provided an entirely noninvasive approach to evaluating endothelial function. 19,24,25 This technique uses increased hemodynamic shear stress during reactive hyperemia as a stimulus for the release of NO. The ultrasound approach has permitted studies of endothelial function in populations of asymptomatic subjects in whom cardiac catheterization is not indicated. The same atherogenic risk factors that impair coronary endothelial function similarly affect endothelial function in brachial arteries. 19 However, the concordance between coronary and brachial endothelial responses when both tests are performed in the same patients is only modest. 18 Moreover, the magnitude of the flow-mediated dilation depends on the specific protocol used to elicit reactive hyperemia, which differs from center to center at the present time. 25 Finally, the methodology is associated with a relatively poor signal-to-noise ratio, which reflects variability in brachial artery size and the current resolution of vascular ultrasound. 25 Despite these limitations, the methodology has proven to be particularly valuable for comparing different populations of patients from single centers and for assessing responses to therapeutic interventions over time. Given the limitations of ultrasound-determined flowmediated dilation, there is continuing interest in the development of better noninvasive approaches to test endothelial function. For example, emerging studies suggest that other noninvasive methods provide information about endothelium-dependent vasodilation, including fingertip pulse arterial tonometer 26 and measures of arterial stiffness. 27,28 Endothelial Function and Clinical Outcomes The postulated antiatherogenic role of NO has been supported by clinical studies. Higher rates of myocardial ischemia or infarction have been reported in humans with polymorphisms of enos that reduce the activity of the enzyme. 29 Among human cardiac transplant recipients, coronary endothelial dysfunction after transplantation has been associated with accelerated coronary arteriosclerosis. 30,31 Several studies have investigated whether endothelial function testing predicts clinical complications associated with atherosclerosis (Table 1). Using several different methods to test endothelial function in coronary and peripheral arteries, patients with endothelial dysfunction had a far greater incidence of adverse cardiovascular events in follow-up compared with patients with preserved endothelial function. This ability of endothelial function testing to predict events was independent of other known risk factors. Although intriguing, these observations have definite limitations. They are largely a retrospective examination of clinical outcomes in patients enrolled in various research protocols in a few laboratories and hence may not be applicable to the population at large. Moreover, as the number of events in each study is small, composite end points consisting of a hard and a soft end point typically have been used. Nonetheless, the totality and consistency of these studies suggest that assessment of endothelial function has the capacity to provide useful prognostic information about future cardiovascular events. Therapeutic Interventions and Endothelial Function Because of the pivotal role that endothelial dysfunction plays in atherosclerosis and its complications, numerous strategies of reversing endothelial dysfunction have been investigated. 2,4 Short-term studies have shown that mechanistically diverse interventions improve endothelial function, including
3 Ganz and Vita Testing Endothelial Vasomotor Function 2051 TABLE 1. Clinical Studies Supporting the Prognostic Value of Endothelial Vasomotor Function Testing Study Population Vascular Bed Test of Endothelial Function No. of Patients Follow-Up, mo Clinical Events Al Suwaidi et al 36 CAD Coronary resistance vessels Acetylcholine MI, cardiovascular death, revascularization, CHF Schächinger et al 37 CAD Epicardial coronary arteries Acetylcholine and flow-mediated dilation Halcox et al 38 CAD Epicardial coronary arteries and resistance vessels MI, cardiovascular death, revascularization, unstable angina, ischemic Acetylcholine MI, cardiovascular death, unstable angina, Perticone et al 39 Hypertension Forearm resistance vessels Acetylcholine Cardiac, cerebrovascular, peripheral vascular Heitzer et al 40 CAD Forearm resistance vessels Acetylcholine MI, cardiovascular deaths, ischemic, revascularization Neunteufl et al 41 CAD Brachial arteries Flow-mediated dilation MI, revascularization Gokce et al 42 PAD Brachial arteries Flow-mediated dilation Cardiovascular death, MI, unstable angina, Modena et al 32 Hypertension, Brachial arteries Flow-mediated dilation Cardiovascular events postmenopausal Gokce et al 43 PAD Brachial arteries Flow-mediated dilation Cardiovascular death, MI, unstable angina, Targonski et al 44 Risk factors, but normal coronary arteries Coronary resistance vessels Acetylcholine Cerebrovascular events CAD indicates coronary artery disease; PAD, peripheral arterial disease; and MI, myocardial infarction. correction of lipid abnormalities, inhibition of angiotensinconverting enzyme or angiotensin II receptor, smoking cessation, exercise, and various dietary interventions. Interestingly, all of these interventions have also been shown to reduce cardiovascular events in clinical outcome studies. During drug development, clinical outcome trials typically require thousands of patients and many years to complete and are associated with prohibitive costs. Hence, surrogate end points such as endothelial function testing have had much appeal in helping to decide which drugs to include in large clinical trials. The observation that an intervention improves endothelial function in a group of patients suggests that the intervention will also reduce cardiovascular risk and holds the promise that endothelial function testing may differentiate responders to treatment from nonresponders. In support of such a role for endothelial function testing, Modena and colleagues 32 observed that improvement in brachial artery flow-mediated dilation after initiation of antihypertensive therapy coincided with a reduction in cardiovascular risk compared with patients with persistent endothelial dysfunction. However, that study lacked a standardized intervention, and further studies will be required to confirm the utility of endothelial function testing for this purpose. Finally, endothelial function does not always correctly predict long-term outcome. For example, hormonal replacement therapy in postmenopausal women is consistently associated with improved endothelial function in peripheral and coronary arteries, 33 but primary and secondary prevention clinical trials have proven negative. Given the complex causal mechanisms of atherosclerosis and the diverse effects of potential interventions, it is likely that no single surrogate end point will be completely predictive of clinical outcome. Accordingly, drug development in the field of atherosclerosis will have to rely on a broad panel of surrogate end points that test the impact of therapy on each key aspect of this disease, including endothelial function, inflammation, thrombosis, and plaque regression. Endothelial Function Testing in the Coronary Risk Assessment of Generally Healthy Subjects Another area of great interest is the potential use of endothelial function to stratify risk in individual subjects. Traditional and newly recognized risk factors account for only a portion of estimated risk for cardiovascular events such as myocardial infarction or coronary heart disease death. It is likely that genetic factors and other unrecognized environmental factors also play a role. Because the endothelium may be a target that integrates the damaging effects of the traditional and unknown risk factors, it has been proposed as a potential barometer of atherosclerosis risk, 34 and as such, studying endothelial function may guide risk assessment and therapy for individuals. C-reactive protein, a biomarker of inflammation, recently received a limited endorsement to serve in that capacity. 35 Routine use of a biomarker for screening has profound implications for healthcare benefits and costs. Accordingly, each potential biomarker must pass rigorous tests, such as those we propose in Table 2. Currently, invasive and noninvasive endothelial function testing may reasonably used to investigate mechanisms of vascular disease and gain insight into the potential utility of new therapies in studies involving groups of patients. However, endothelial function testing does not meet most of the criteria in Table 2 as a biomarker for use in individual patients, so much work remains. Fortunately, simpler methods for endothelial function testing are currently in development and may prove helpful in that regard.
4 2052 Circulation October 28, 2003 TABLE 2. Assessment of Cardiovascular Risk in Apparently Healthy Individuals: Optimal Characteristics for Proposed New Tests Nature of the test Test should be simple, noninvasive, commercially available, and cost-effective. Test should be reproducible and standardized internationally. Ability to predict risk Ability to predict risk should be established in prospective studies. Test should have population norms to guide results. Test results should be generalized to various population groups. Relationship to established tests of risk New test should add to the predictive value of established tests. New test should be particularly useful in refining the risk of mediumor low-risk subjects. Function as a surrogate end point New test should be useful as a screen for drug development. New test should identify individual patients who will benefit from therapy. An improvement in the new test should predict a reduction in the risk of clinical events. Summary Basic observations by Furchgott and others have stimulated widespread interest in investigations of endothelial function in humans. This translational research has come to fruition. Much progress has been made in elucidating the biological mechanisms of human endothelial dysfunction, its relationship to atherosclerosis, and its clinical manifestations. Evidence for the importance of endothelial function has been strengthened by studies that relate endothelial dysfunction to future clinical events. Endothelial function testing may provide a useful target in the discovery and development of new therapies for the pharmaceutical industry. Further research is needed to establish endothelial function testing in the risk stratification and decisions regarding treatment of generally healthy subjects. Acknowledgments Dr Ganz s work is supported by National Institutes of Health grants P50 HL and 1P50-HL Dr Vita s work is supported by National Institutes of Health grants HL55993, HL60886, HL70100, and HL/AI References 1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: Behrendt D, Ganz P. Endothelial function: from vascular biology to clinical applications. Am J Cardiol. 2002;90:40L 48L. 3. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest. 1997;100: Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001;12: Yang Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation. 2000;101: Gimbrone MA Jr. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol. 1995;75:67B 70B. 7. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315: Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87: Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23: Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81: Kanani PM, Sinkey CA, Browning RL, et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 1999;100: Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA. 1997;278: Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;97: McLenachan JM, Vita J, Fish DR, et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation. 1990;82: Quyyumi AA, Dakak N, Andrews NP, et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995; 92: Zeiher AM, Krause T, Schachinger V, et al. Impaired endotheliumdependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995;91: Hasdai D, Gibbons RJ, Holmes DR Jr, et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96: Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26: Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24: Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75: 71B 74B. 21. Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87: Selwyn AP, Ganz P. Myocardial ischemia in coronary disease. N Engl J Med. 1988;318: Ting HH, Timimi FK, Haley EA, et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95: Lieberman EH, Gerhard MD, Uehata A, et al. Flow-induced vasodilation of the human brachial artery is impaired in patients 40 years of age with coronary artery disease. Am J Cardiol. 1996;78: Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39: Bonetti PO, Barsness GW, Keelan PC, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003;41: Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;23: Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens. 2001;14: 258S 263S. 29. Leeson CP, Hingorani AD, Mullen MJ, et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental
5 Ganz and Vita Testing Endothelial Vasomotor Function 2053 and dietary factors to influence endothelial function. Circ Res. 2002;90: Davis SF, Yeung AC, Meredith IT, et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation. 1996;93: Hollenberg SM, Klein LW, Parrillo JE, et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation. 2001;104: Modena MG, Bonetti L, Coppi F, et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. JAm Coll Cardiol. 2002;40: Ganz P. Vasomotor and vascular effects of hormone replacement therapy. Am J Cardiol. 2002;90:11F 16F. 34. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation. 2002;106: Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107: Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101: Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101: Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106: Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104: Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104: Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86: Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105: Gokce N, Keaney JF Jr, Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41: Targonski PV, Bonetti PO, Pumper GM, et al. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation. 2003;107:
Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function. A Prospective Study
Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function A Prospective Study Noyan Gokce, MD; John F. Keaney, Jr, MD; Liza M. Hunter, ANP; Michael
More informationThe Clinical Implications of Endothelial Dysfunction
Journal of the American College of Cardiology Vol. 42, No. 7, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00994-x
More informationEndothelial dysfunction and the role of hypertension in Nepalese subjects with major coronary risk factors
Original Article Endothelial dysfunction and the role of hypertension in Nepalese subjects with major coronary risk factors Mani Prasad Gautam, 1 Samir Gautam, 2 Usha Ghimire, 3 Sogunuru Guruprasad, 4
More informationThe Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
More informationAcute Effects of Vasoactive Drug Treatment on Brachial Artery Reactivity
Journal of the American College of Cardiology Vol. 40, No. 4, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02034-X
More informationClinical Investigation and Reports
Clinical Investigation and Reports Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease Volker Schächinger, MD; Martina B. Britten, MD; Andreas M.
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationPrognostic Value of Brachial Artery Endothelial Function and Wall Thickness
Journal of the American College of Cardiology Vol. 46, No. 6, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.070
More informationLa Trombosi Arteriosa
La Trombosi Arteriosa Prof. Giovanni Davì Medicina Interna Chieti Platelet activation and thrombosis Harrison 19 edizione Platelets are essential for primary hemostasis and repair of the endothelium They
More informationOver the last two decades it has become evident that the
Endothelial Function A Critical Determinant in Atherosclerosis? Ulf Landmesser, MD; Burkhard Hornig, MD; Helmut Drexler, MD Abstract Common conditions predisposing to atherosclerosis, such as hypercholesterolemia,
More informationA study of brachial artery flow mediated dilatation and carotid intima media thickness in subjects having risk factors for coronary artery disease
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20171037 A study of brachial
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationEuropean Heart Journal (1999) 20, Article No. euhj , available online at on
European Heart Journal (1999) 20, 1676 1680 Article No. euhj.1999.1689, available online at http://www.idealibrary.com on Vitamin C improves endothelial function of epicardial coronary arteries in patients
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/28524 holds various files of this Leiden University dissertation Author: Djaberi, Roxana Title: Cardiovascular risk assessment in diabetes Issue Date: 2014-09-04
More informationRelationship Between Endothelial Dysfunction and Nitric Oxide Production in Young Male Smokers
J Cardiol 2001 ; 38: 21 28 Relationship Between Endothelial Dysfunction and Nitric Oxide Production in Young Male Smokers Tomoyuki Taku Takaharu Kotaro Sachie Minoru Shunsuke Iwao Kazuyuki Katsuharu Tohru
More informationAN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE
AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE Good for your patients. Good for your practice. Using the AngioDefender system to complement your patients care routine enables you to: Improve your patient
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More informationEVect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms
Heart 1999;82:689 693 689 Heart Institute, São Paulo University, Av Dr Enéas de Carvalho Aguiar 44, 05403-000 São Paulo, Brazil A P Mansur C V Serrano J C Nicolau L A M César J A F Ramires Correspondence
More informationThe Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research
The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research I. Basic Physiology of Circulation A. The Vascular Endothelium The endothelium is a complex
More informationEndothelium-dependent vasodilatation in forearm is impaired in stroke patients
Journal of Internal Medicine 26; 259: 569 575 doi:1.1111/j.1365-2796.26.1635.x Endothelium-dependent vasodilatation in forearm is impaired in stroke patients A. STENBORG 1, A. TERENT 1 & L. LIND 1,2 From
More informationJoshua A. Beckman, MD. Brigham and Women s Hospital
Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationMicrovascular Disease: How to Diagnose and What s its Treatment
Microvascular Disease: How to Diagnose and What s its Treatment Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of
More informationWatermark. Interaction between Neuropathy and PAD
Interaction between Neuropathy and PAD Javier La Fontaine, DPM, MS Associate Professor Department of Plastic Surgery UT Southwestern Medical Center Dallas, Texas Objectives Understand vascular disease
More informationPolyphenols and cardiovascular disease: effects on endothelial and platelet function 1 4
Polyphenols and cardiovascular disease: effects on endothelial and platelet function 1 4 Joseph A Vita ABSTRACT Epidemiologic studies suggest that higher polyphenol intake from fruits and vegetables is
More informationAs the major regulator of vascular homeostasis, the
Role of Endothelial Dysfunction in Atherosclerosis Jean Davignon, MD; Peter Ganz, MD Abstract As the major regulator of vascular homeostasis, the endothelium exerts a number of vasoprotective effects,
More informationImaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
More informationEicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different?
Eicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different? Trevor A Mori, Ph.D., Professor, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth,
More informationAging is a well-documented cardiovascular risk factor.
Physical Activity Prevents Age-Related Impairment in Nitric Oxide Availability in Elderly Athletes Stefano Taddei, MD; Fabio Galetta, MD; Agostino Virdis, MD; Lorenzo Ghiadoni, MD; Guido Salvetti, MD;
More informationBrachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study
Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study Joseph A. Vita, MD; John F. Keaney, Jr, MD; Martin G. Larson, ScD; Michelle J. Keyes, MA; Joseph M. Massaro,
More informationOral Disease as a Risk Factor for Acute Coronary Syndrome Single Center Experience
1167 International Journal of Collaborative Research on Internal Medicine & Public Health Oral Disease as a Risk Factor for Acute Coronary Syndrome Single Center Experience Sachin Kumar Amruthlal Jain
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationRelationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases
Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Introduction Reactive oxygen species (ROS),such as superoxide and
More informationCardiovascular Division, Brigham and Women s Hospital, Harvard Medical School
Low Endothelial Shear Stress Upregulates Atherogenic and Inflammatory Genes Extremely Early in the Natural History of Coronary Artery Disease in Diabetic Hyperlipidemic Juvenile Swine Michail I. Papafaklis,
More informationPearls & Pitfalls in nuclear cardiology
Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer
More informationPreclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD
Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More information10/17/16. Assessing cardiovascular risk through use of inflammation testing
Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response
More informationStable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology
Stable Ischemic Heart Disease Ivan Anderson, MD RIHVH Cardiology Outline Review of the vascular biology of atherosclerosis Why not just cath everyone with angina? Medical management of ischemic cardiomyopathy
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationHow to detect early atherosclerosis ; focusing on techniques
How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial
More informationFlow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide
Clinical Science (2001) 101, 629 635 (Printed in Great Britain) 629 Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide Sagar N. DOSHI*, Katerina
More informationCoronary heart disease is the leading cause of morbidity
Clinical Investigation and Reports Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction Jassim Al Suwaidi, MB, ChB; Shuichi Hamasaki, MD; Stuart T. Higano, MD;
More informationSurrogate Markers for Cardiovascular Disease: Functional Markers Jay N. Cohn, Arshed A. Quyyumi, Norman K. Hollenberg and Kenneth A.
Surrogate Markers for Cardiovascular Disease: Functional Markers Jay N. Cohn, Arshed A. Quyyumi, Norman K. Hollenberg and Kenneth A. Jamerson Circulation 2004;109;31-46 DOI: 10.1161/01.CIR.0000133442.99186.39
More informationClinical aspects of assessment of endothelial function
Pharmacological Reports 2006, 58, suppl., 33 40 ISSN 1734-1140 Copyright 2006 by Institute ofpharmacology Polish Academy ofsciences Review Clinical aspects of assessment of endothelial function Jaros³aw
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationContents. EDITORIAL Endothelial dysfunction G. Jackson...3. BASIC ARTICLE Endothelial function and dysfunction P. Vanhoutte...5
Contents EDITORIAL Endothelial dysfunction G. Jackson...3 BASIC ARTICLE Endothelial function and dysfunction P. Vanhoutte...5 MAIN CLINICAL ARTICLE Clinical expression of endothelial dysfunction W. Dunn,
More informationVALVULO-METABOLIC RISK IN AORTIC STENOSIS
January 2008 (Vol. 1, Issue 1, pages 21-25) VALVULO-METABOLIC RISK IN AORTIC STENOSIS By Philippe Pibarot, DVM, PhD, FACC, FAHA Groupe de Recherche en Valvulopathies (GRV), Hôpital Laval Research Centre
More informationClassification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy
Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial
More informationObjectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?
Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation
More informationKEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers
CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes
More informationPCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure
PCTH 400 LAST LECTURE Endothelial dysfunction and cardiovascular diseases. Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure Blood pressure
More informationWho Cares About the Past?
Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring
More informationDiabetes and Occult Coronary Artery Disease
Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York
More informationData Alert #2... Bi o l o g y Work i n g Gro u p. Subject: HOPE: New validation for the importance of tissue ACE inhibition
Vascular Bi o l o g y Work i n g Gro u p c/o Medical Education Consultants, In c. 25 Sy l van Road South, We s t p o rt, CT 06880 Chairman: Carl J. Pepine, MD Professor and Chief Division of Cardiovascular
More informationSummary. Introduction
Clin Physiol Funct Imaging (2008) doi: 10.1111/j.1475-097X.2008.00816.x 1 Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationOVERVIEW OF CLINICAL TRIALS
Vascular Bi o l o g y in Clinical Pr a c t i c e Vol. 1, No. 2 A CME Monograph Series OVERVIEW OF CLINICAL TRIALS TO IMPROVE ENDOTHELIAL FUNCTION GUEST EDITOR Arshed A. Quyyumi, MD, MRCP National Institutes
More informationBIOAUTOMATION, 2009, 13 (4), 89-96
Preliminary Results оf Assessment of Systolic and Diastolic Function in Patients with Cardiac Syndrome X Using SPECT CT Tsonev Sv. 1, Donova T. 1, Garcheva M. 1, Matveev M. 2 1 Medical University Sofia
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationHYPERCHOLESTEROLEMIA is a health risk,
488 THE NEW ENGLAND JOURNAL OF MEDICINE Feb. 23, 199 THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION TODD J. ANDERSON, M.D., IAN T. MEREDITH, M.B.,
More informationThe Case for Intravenous EDTA Chelation Therapy, August, 2006 update.
The Case for Intravenous EDTA Chelation Therapy, August, 2006 update. Positive Dr. Johanna Mendez (Columbia, S.A.) and Dr. Martin Dayton discussing contents of a chelation treatment in a clinical setting
More informationPulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease
Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease Vascular Medicine 15(4) 299 305 The Author(s) 2010 Reprints and permission: sagepub.
More informationOcclusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation
Clinical Science (2000) 99, 261 267 (Printed in Great Britain) 261 Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation Karen
More informationRisk Stratification for CAD for the Primary Care Provider
Risk Stratification for CAD for the Primary Care Provider Shimoli Shah MD Assistant Professor of Medicine Directory, Ambulatory Cardiology Clinic Knight Cardiovascular Institute Oregon Health & Sciences
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More information1048 JACC Vol. 27, No. 5 April 1996:
1048 JACC Vol. 27, No. 5 SPECIAL ARTICLE Ongoing Clinical Trials of Angiotensin-Converting Enzyme Inhibitors for Treatment of Coronary Artery Disease in Patients With Preserved Left Ventricular Function
More information12 Lead EKG Chapter 4 Worksheet
Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining
More informationAngioDefender. A man is as old as his arteries. Dr. Thomas Sydenham, British physician ( ) known as the English Hippocrates
AngioDefender A man is as old as his arteries Dr. Thomas Sydenham, British physician (1624-1689) known as the English Hippocrates Since the dawn of modern clinical medicine, when patient observation and
More informationThe endothelium controls vascular tone, coagulation, and
Preventive Cardiology Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults The Cardiovascular Risk in Young Finns Study Markus Juonala, MD; Jorma S.A.
More informationInterleukin-10 Serum Levels and Systemic Endothelial Vasoreactivity in Patients With Coronary Artery Disease
Journal of the American College of Cardiology Vol. 44, No. 1, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.02.054
More informationData Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.
1994--4 Vascular Biology Working Group www.vbwg.org c/o Medical Education Consultants, LLC 25 Sylvan Road South, Westport, CT 688 Chairman: Carl J. Pepine, MD Eminent Scholar American Heart Association
More informationClinical application of Arterial stiffness. pulse wave analysis pulse wave velocity
Clinical application of Arterial stiffness pulse wave analysis pulse wave velocity Arterial system 1. Large arteries: elastic arteries Aorta, carotid, iliac, Buffering reserve: store blood during systole
More informationC-reactive protein: a marker or a player?
C-reactive protein: a marker or a player? Thomas Nyström, Thomas Nyström To cite this version: Thomas Nyström, Thomas Nyström. C-reactive protein: a marker or a player?. Clinical Science, Portland Press,
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More information63 yo woman with chest pain
63 yo woman with chest pain Coronary Microvascular Disease: Does It Exist? EA Amsterdam, MD Distinguished Professor Cardiology and Internal Medicine UC Davis School of Medicine and Medical Center Sacramento,
More informationASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION
ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,
More informationReceived: March 2008; in final form May 2008.
RELATIONSHIP BETWEEN BRACHIAL ARTERY FLOW- MEDIATED DILATION AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN THE MIDDLE-AGED SUBJECTS WITH LOW CARDIOVASCULAR RISK GERMAINE SĂVOIU*, LAVINIA NOVEANU**, O. FIRA-MLADINESCU*,
More informationPathophysiology of Coronary Microvascular Dysfunction
Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive
More informationState of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC
State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationThe Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction
The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction Cardiovascular Center, Korea University Guro Hospital 2007. 4. 20 Seung-Woon Rha, MD, PhD Introduction 1.
More informationFFR Incorporating & Expanding it s use in Clinical Practice
FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel
More informationWomen and Coronary Artery Disease:
Women and Coronary Artery Disease: Less is More? Interventional Cardiology 2017 32 th Annual International Symposium Snow Mass March 5-10 Yolande Appelman MD, PhD,FESC EAPCI-Women Interventional Cardiologist
More informationChest pain affects 20% to 40% of the general population during their lifetime.
Chest pain affects 20% to 40% of the general population during their lifetime. More than 5% of visits in the emergency department, and up to 40% of admissions are because of chest pain. Chest pain is a
More informationAmbulatory Care Conference
Ambulatory Care Conference David Stultz, MD August 28, 2002 Case Presentation 50 year old white female presents to ED with substernal chest pain. Pain started while driving, is left substernal in location
More informationCURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O.
CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O. INTRODUCTION Form of imprisonment in 1818 Edward Smith s observations TECHNIQUE Heart rate Blood pressure ECG parameters Physical appearance INDICATIONS
More informationIndian Heart Journal
Indian Heart Journal 70 (2018) 622 626 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj Original Article Correlation of endothelial dysfunction
More informationATEF ELBAHRY,FACA,FICA,MISCP,FVBWG.
Hyperglycemia and Coronary Events: where is the link? ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG. Cardiovascular (CV) disease is the primary complication of diabetes ~65% of deaths are due to CV disease Coronary
More informationKey words: coronary artery calcification; C-reactive protein; electron beam CT; endothelial function
Enhanced Coronary Calcification Determined by Electron Beam CT Is Strongly Related to Endothelial Dysfunction in Patients With Suspected Coronary Artery Disease* Po-Hsun Huang, MD; Lung-Ching Chen, MD;
More informationChoosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman
Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease Greg Wellenius Joel Kaufman Framework for Choosing Subclinical Outcomes To Study What clinical outcomes
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationRetinal vessel analysis in dyslipidemia: The eye, a window to the body s microcirculation
Project Summary SWISS LIPID RESEARCH AWARD 2017 SPONSORED BY AMGEN Retinal vessel analysis in dyslipidemia: The eye, a window to the body s microcirculation Matthias P. Nägele, M.D. 1, Jens Barthelmes,
More informationVariability of Peripheral Arterial Tonometry in the Measurement of Endothelial Function in Healthy Men
Variability of Peripheral Arterial Tonometry in the Measurement of Endothelial Function in Healthy Men Jianmin Liu, MD; Jingzhu Wang, MS; Yan Jin, MS; Hans J. Roethig, MD, PhD, FCP, FFPM; Martin Unverdorben,
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More information